首页> 外文期刊>Human Genetics >Genetic variation in the base excision repair pathway and bladder cancer risk
【24h】

Genetic variation in the base excision repair pathway and bladder cancer risk

机译:基本切除修复途径的遗传变异与膀胱癌风险

获取原文
获取原文并翻译 | 示例
           

摘要

Genetic polymorphisms in DNA repair genes may impact individual variation in DNA repair capacity and alter cancer risk. In order to examine the association of common genetic variation in the base-excision repair (BER) pathway with bladder cancer risk, we analyzed 43 single nucleotide polymorphisms (SNPs) in 12 BER genes (OGG1, MUTYH, APEX1, PARP1, PARP3, PARP4, XRCC1, POLB, POLD1, PCNA, LIG1, and LIG3). Using genotype data from 1,150 cases of urinary bladder transitional cell carcinomas and 1,149 controls from the Spanish Bladder Cancer Study we estimated odds ratios (ORs) and 95% confidence intervals (CIs) adjusting for age, gender, region and smoking status. SNPs in three genes showed significant associations with bladder cancer risk: the 8-oxoG DNA glycosylase gene (OGG1), the Poly (ADP-ribose) polymerase family member 1 (PARP1) and the major gap filling polymerase-β (POLB). Subjects who were heterozygous or homozygous variant for an OGG1 SNP in the promoter region (rs125701) had significantly decreased bladder cancer risk compared to common homozygous: OR (95%CI) 0.78 (0.63–0.96). Heterozygous or homozygous individuals for the functional SNP PARP1 rs1136410 (V762A) or for the intronic SNP POLB rs3136717 were at increased risk compared to those homozygous for the common alleles: 1.24 (1.02–1.51) and 1.30 (1.04–1.62), respectively. In summary, data from this large case-control study suggested bladder cancer risk associations with selected BER SNPs, which need to be confirmed in other study populations.
机译:DNA修复基因的遗传多态性可能会影响DNA修复能力的个体变异并改变患癌症的风险。为了检查碱基切除修复(BER)途径中常见遗传变异与膀胱癌风险的关联,我们分析了12个BER基因(OGG1,MUTYH,APEX1,PARP1,PARP3,PARP4)中的43个单核苷酸多态性(SNP) ,XRCC1,POLB,POLD1,PCNA,LIG1和LIG3)。使用来自西班牙膀胱癌研究的1,150例膀胱移行细胞癌和1149例对照的基因型数据,我们估算了根据年龄,性别,地区和吸烟状况进行调整的优势比(OR)和95%置信区间(CI)。三个基因中的SNPs与膀胱癌风险显着相关:8-oxoG DNA糖基化酶基因(OGG1),聚(ADP-核糖)聚合酶家族成员1(PARP1)和主要的缺口填补聚合酶-β(POLB)。与普通纯合子相比,在启动子区域中的OGG1 SNP为纯合子或纯合子的受试者(rs125701)与普通纯合子相比,具有显着降低的膀胱癌风险:OR(95%CI)0.78(0.63-0.96)。与普通等位基因纯合子相比,功能性SNP PARP1 rs1136410(V762A)或内含SNP POLB rs3136717的杂合子或纯合子患病的风险更高:分别为1.24(1.02-1.51)和1.30(1.04-1.62)。总而言之,这项大型病例对照研究的数据表明,膀胱癌的风险与所选的BER SNP相关,这需要在其他研究人群中得到证实。

著录项

  • 来源
    《Human Genetics》 |2007年第2期|233-242|共10页
  • 作者单位

    Division of Cancer Epidemiology and Genetics Department of Health and Human Services National Cancer Institute Bethesda MD USA;

    Division of Cancer Epidemiology and Genetics Department of Health and Human Services National Cancer Institute Bethesda MD USA;

    Division of Cancer Epidemiology and Genetics Department of Health and Human Services National Cancer Institute Bethesda MD USA;

    Department of Health and Human Services Core Genotype Facility at the Advanced Technology Center of the National Cancer Institute Bethesda MD USA;

    Division of Cancer Epidemiology and Genetics Department of Health and Human Services National Cancer Institute Bethesda MD USA;

    Universidad de Oviedo Oviedo Spain;

    Universitat Pompeu Fabra Barcelona Spain;

    Hospital Universitario de Elche Elche Spain;

    Unidad de Investigación Hospital Universitario de Canarias La Laguna Spain;

    Division of Cancer Epidemiology and Genetics Department of Health and Human Services National Cancer Institute Bethesda MD USA;

    Division of Cancer Epidemiology and Genetics Department of Health and Human Services National Cancer Institute Bethesda MD USA;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号